相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics and Pharmacodynamics of TMC207 and Its N-Desmethyl Metabolite in a Murine Model of Tuberculosis
Marie-Claude Rouan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
A. H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers: AIDS Clinical Trials Group Study A5267
Kelly E. Dooley et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds
Umesh M. Hanumegowda et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
Semi-Mechanistic Population Pharmacokinetic Drug-Drug Interaction Modelling of a Long Half-Life Substrate and Itraconazole
Thorsten Lehr et al.
CLINICAL PHARMACOKINETICS (2010)
TMC207: the first compound of a new class of potent anti-tuberculosis drugs
Alberto Matteelli et al.
FUTURE MICROBIOLOGY (2010)
Screening for phospholipidosis induced by central nervous drugs: Comparing the predictivity of an in vitro assay to high throughput in silico assays
Mesens Natalie et al.
TOXICOLOGY IN VITRO (2010)
Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents
Katherine M. Coyne et al.
AIDS (2009)
Assessment of the Impact of Renal Impairment on Systemic Exposure of New Molecular Entities: Evaluation of Recent New Drug Applications
Y. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Effect of Different Durations of Ketoconazole Dosing on the Single-Dose Pharmacokinetics of Midazolam: Shortening the Paradigm
S. A. Stoch et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
Evan W. Orenstein et al.
LANCET INFECTIOUS DISEASES (2009)
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis
R. Rustomjee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The role of ethnicity in variability in response to drugs: Focus on clinical pharmacology studies
S. U. Yasuda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Prevention of drug carryover effects in studies assessing antimycobacterial efficacy of TMC207
Nacer Lounis et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Diarylquinolines target subunit c of mycobacterial ATP synthase
Anil Koul et al.
NATURE CHEMICAL BIOLOGY (2007)
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
K Andries et al.
SCIENCE (2005)
Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities
Y Nishimura et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Apparent mechanism-based inhibition of human CYP3A in-vitro by lopinavir
JL Weemhoff et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
Genetic contribution to variable human CYP3A-mediated metabolism
JK Lamba et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: Potent inhibition of CYP2C19 and CYP3A
Z Desta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
